Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 14 Colorectal Neoplasms 14 Colonic Neoplasms 14 Stomach Neoplasms 10 Ovarian Neoplasms 6 Carcinoma, Hepatocellular 5 Gastrointestinal Stromal Tumors 4 Carcinoma, Renal Cell 4 Pancreatic Neoplasms 3 Liver Neoplasms 3 Peritoneal Neoplasms 2 Neoplastic Cells, Circulating 2 Neoplasms 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Uterine Cervical Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neuroendocrine Tumors 1 Ovarian Cysts 1 Obesity, Morbid 1 Neoplasm Metastasis 1 Myofibroma 1

Interventions

Metformin 149 Clomiphene 50 Letrozole 38 Inositol 34 Folic Acid 18 Exercise 17 Progesterone 15 Ethinyl Estradiol 13 Chorionic Gonadotropin 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Estradiol 12 Contraceptives, Oral 11 cetrorelix 10 Pioglitazone 10 High-Intensity Interval Training 10 Tablets 9 Spironolactone 9 Cholecalciferol 9 Triptorelin Pamoate 8 Diet 8 Vitamin D 7 Thioctic Acid 7 Menotropins 7 Liraglutide 7 Acupuncture Therapy 7 drospirenone 6 Ovidrel 6 Gonadotropins 6 Flutamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycystic Ovary Syndrome × Laparoscopy × Clear all

NCT06102629 2023-10-26

PCOS-01

Asian Institute of Gastroenterology, India

Phase NA Not yet recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡